الفهرس | Only 14 pages are availabe for public view |
Abstract This study aimed to compare the phenytoin and magnesium sulphate in management of severe pre-eclampsia and eclampsia as regards their anticonvulsant effects, and maternal and fetal side effects. This study has been carried out in Zagazig University Hospitals, where fourty patients with severe pre-eclampsia with comparable age and gestational age. There were no statistically significant differences between the two groups regarding blood pressure, degree of proteinuria, platelet count and serum albumin chosen and then randomly divided into two groups: Group (A): Magnesium sulphate group: It includes twenty patients treated by magnesium sulphate; all were primigravidae, their ages ranged from 18-35 years and the gestational age ranged from 34-40 weeks. Group (B): Phenytoin group: It includes twenty patients treated by phenytoin sodium, their ages ranged from 17-38 years and gestational ages ranged from 34-40 weeks |